Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Aumolertinib Promising Maintenance Therapy in EGFR+ NSCLC
SAN DIEGO — Treatment with the estimated glomerular filtration rate (EGFR) tyrosine kinase inhibitor (TKI) aumolertinib after chemoradiation was associated significant improvement in progression-free survival compared with placebo in patients with unresectable stage III EGFR-mutant non–small cell lung cancer (NSCLC).…
English